In medical terms, VAD most commonly stands for ventricular assist device, a mechanical pump surgically implanted in the chest to help a weakened heart move blood through the body. VAD can also refer to a vascular access device, which is a catheter or port used to deliver fluids, nutrition, or medication into a vein. The ventricular assist device is the more widely referenced meaning, especially in cardiology, and it plays a critical role for people with severe heart failure.
VAD as a Ventricular Assist Device
A ventricular assist device is a battery-powered pump placed inside the chest during open-heart surgery. It doesn’t replace the heart. Instead, it works alongside it, taking over some or most of the pumping work that the heart can no longer handle on its own. The device draws blood from a weakened ventricle (one of the heart’s main pumping chambers) and pushes it into the aorta, the large artery that delivers blood to the rest of the body.
There are three types based on which part of the heart needs support:
- LVAD (left ventricular assist device): Supports the left ventricle, which pumps blood to the body. This is by far the most common type.
- RVAD (right ventricular assist device): Supports the right ventricle, which sends blood to the lungs.
- BiVAD (biventricular assist device): Supports both ventricles at once.
Modern LVADs use continuous-flow technology, meaning they spin blood forward in a steady stream rather than mimicking the heart’s natural pulse. The latest generation uses a magnetically levitated rotor, which reduces friction and wear on the device’s internal parts.
Why Someone Gets a VAD
VADs are reserved for people with severe, chronic heart failure, specifically those whose hearts are too weak to keep up with the body’s needs despite medication. There are two main reasons a doctor would recommend one.
The first is called bridge to transplant. The patient is already approved and waitlisted for a heart transplant, but their heart is failing faster than a donor heart is likely to become available. The VAD keeps them alive and functional while they wait.
The second is destination therapy. This applies to patients who aren’t candidates for a heart transplant, whether because of age, other health conditions, or personal choice. For these patients, the VAD is a long-term, potentially permanent treatment. To qualify, a person generally needs to have a severely reduced pumping capacity (an ejection fraction below 25%) and must have already tried and failed to improve on optimal heart failure medications for at least 45 of the previous 60 days.
Living With a VAD
A VAD has both internal and external components. The pump itself sits inside the chest, but a thin cable called a driveline exits through the skin of the abdomen and connects to an external controller. This controller is a small computer that monitors the pump’s performance, displays operating information, and sounds alarms if something needs attention. Patients carry it in a holster vest or belt attachment at all times.
Power comes from a pair of rechargeable lithium-ion batteries that provide 10 to 17 hours of use on a full charge, depending on activity level. Patients are sent home with at least four batteries so a fresh pair is always ready. They also receive a shower bag to protect the equipment, a backup controller, and a neck strap. At home, the device can also plug into a wall-powered unit.
The driveline exit site on the abdomen requires daily cleaning and dressing changes to prevent infection. Submerging the driveline in water (swimming, baths) is not allowed. These daily routines become a central part of life with a VAD.
Surgery and Recovery
VAD implantation is a major open-heart surgery performed under general anesthesia. Afterward, most patients spend four to five days in the ICU before moving to a regular hospital room. The total hospital stay averages 14 to 21 days. During that time, physical and occupational therapists begin working with the patient to rebuild strength, and a dietitian helps adjust nutrition for recovery.
Before discharge, patients and their caregivers receive extensive training on how to manage the controller, swap batteries, care for the driveline site, and respond to alarms. Having a trained caregiver at home is a requirement for most VAD programs.
Risks and Complications
VADs are life-saving devices, but they carry significant risks. Up to 60% of patients experience a complication within the first six months, and by two years, roughly 80% have had at least one adverse event.
Bleeding is the most common problem. Between 20% and 40% of patients experience a non-surgical bleeding event within the first 30 days. Gastrointestinal bleeding is a particular concern: the cumulative risk reaches about 21% at one year and 31% at five years. The continuous-flow design of modern pumps can damage a clotting protein in the blood, making patients more prone to these episodes.
Infection is the second leading cause of death in patients who survive the initial recovery period. Infection rates range from 30% to 50%, with pneumonia and bloodstream infections being the most frequent types, followed by infections at the driveline exit site (about 19% within the first year). The bacteria responsible are usually skin organisms that travel along the driveline.
Stroke is another serious risk. Hemorrhagic stroke (bleeding in the brain) occurs in about 11% of patients within two years. Ischemic stroke (a clot blocking blood flow to the brain) happens at a rate of roughly 6 to 8 events per 100 patients per year. Blood clots can also form inside the pump itself, a complication known as pump thrombosis. Right ventricular failure, where the unsupported right side of the heart struggles under changed blood flow conditions, develops in about 11% of patients after LVAD placement.
How Long a VAD Lasts
Survival outcomes with the current generation of magnetically levitated LVADs are encouraging. One-year survival is approximately 86%, five-year survival is 60%, and seven-year survival is about 52%. These numbers reflect a meaningful improvement over earlier pump designs and continue to improve as surgical techniques and post-implant care evolve.
For bridge-to-transplant patients, the VAD often needs to function for months to a few years until a donor heart becomes available. For destination therapy patients, the device may run for many years, and some patients have lived on VAD support for over a decade.
VAD as a Vascular Access Device
The other medical meaning of VAD refers to vascular access devices, which are catheters or ports used to deliver treatments directly into a vein. These are common across many areas of medicine, from chemotherapy to long-term IV antibiotics to nutrition support. The main types include peripherally inserted central catheters (PICC lines), which are threaded through an arm vein into a large vein near the heart; central venous lines, which are placed into a large vein in the neck, chest, or groin; and implantable ports (often called port-a-caths), which sit entirely under the skin and can be accessed with a needle when needed. Unlike ventricular assist devices, vascular access devices are relatively simple, routine medical tools used in both inpatient and outpatient settings.